Skip to main content

Table 2 Clinical results and complications

From: Hydroxyapatite-coated cementless total hip arthroplasty for patients undergoing dialysis: a study of 30 hips with a minimum follow-up period of 5 years

  

p-value

Operative time, min

39.6 ± 11.3 (25–57)

 

Intraoperative blood loss, g

230.2 ± 109.8 (60–410)

 

Postoperative blood loss, g

300.8 ± 209.1 (20–730)

 

Harris hip scores

 Total before THA

40.2 ± 11.4 (19–74)

< 0.0001

 Total at final follow-up

83.7 ± 11.5 (51–95)

 Pain before THA

13.0 ± 7.0 (0–20)

< 0.0001

 Pain at final follow-up

41.1 ± 4.7 (30–44)

 Function before THA

23.6 ± 6.9 (6–30)

< 0.0001

 Function at final follow-up

38.4 ± 8.1 (18–47)

 Deformity before THA

0.2 ± 0.6 (0–2)

1.000

 Deformity at final follow-up

0.2 ± 0.6 (0–2)

 ROM before THA

3.4 ± 0.8 (2–5)

0.0067

 ROM at final follow-up

4.0 ± 0.7 (3–5)

Autogenous bone graft

13 (43.3)

 

Complications

 Fracture

1 (3.3)

 

 Transfusion

8 (26.7)

 

 Shunt blockage

2 (6.7)

 

 Infection

1 (3.3)

 

 Dislocation

2 (6.7)

 

 Nerve palsy

0 (0)

 

 Loosening (acetabular, femoral)

2 (6.7), 1 (3.3)

 

 Osteolysis (acetabular, femoral)

1 (3.3), 1 (3.3)

 
  1. Data are presented as the mean ± standard deviation (range) or number of hips (%). THA total hip arthroplasty, ROM range of motion